HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes



(MedPage Today) — Nucleoside reverse transcriptase inhibitors — antiretroviral drugs approved to treat HIV and hepatitis B — were associated with a lower incidence of Alzheimer’s disease in two large insurance databases. (Alzheimer’s &amp…



Source link : https://www.medpagetoday.com/neurology/generalneurology/115568

Author :

Publish date : 2025-05-13 18:41:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version